Zymeworks (ZYME) Treasury Shares (2024 - 2026)

Name: Zymeworks (ZYME) Treasury Shares (2024 - 2026) | Business Quant
Creator: Business Quant

Zymeworks recorded quarterly Treasury Shares of $3.2 million in Q1 2026, up 72.07% quarter-over-quarter from $1.9 million in Q4 2025.

Zymeworks' Treasury Shares history runs 3 years deep, the most recent figure standing at $3.2 million for Q1 2026.

In Q1 2026, Treasury Shares changed N/A year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (changed N/A YoY), while the FY2025 annual figure was $1.9 million, down 27.05% from the prior year.
Treasury Shares came in at $3.2 million for Q1 2026 at Zymeworks, up from $1.9 million in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $3.2 million in Q1 2026 to a low of $1.0 million in Q3 2025.
A 3-year average of $2.1 million and a median of $1.9 million in 2025 frame the typical range for Treasury Shares.
On a YoY basis, Treasury Shares climbed as much as 27.05% in 2025 and fell as far as 43.45% in 2025.
Zymeworks' Treasury Shares stood at $2.5 million in 2024, then fell by 27.05% to $1.9 million in 2025, then soared by 72.07% to $3.2 million in 2026.
According to Business Quant data, Treasury Shares over the past three periods registered $3.2 million, $1.9 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	265,401.92
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	700,000.00
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	34.70 Mn
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Zymeworks	1.84 Bn	1.47 Bn	-	3.20 Mn

Download Data 🔒